 |
|
|
| |
The clinical relevance of potential drug-drug interactions (DDIs) with bictegravir/ emtricitabine/ tenofovir alafenamide (B/F/TAF)
-Real-world data from the German IQVIA prescription database
|
| |
| |
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
TimUmland1,Hans-JurgenStellbrink2,MartaCalvo3,AstridZahn3
1Alexander Apotheke, Hamburg, Germany; 2Infektionsmedizinisches Centrum Hamburg (ICH), Hamburg, Germany; 3Gilead Sciences GmbH, Munich, Germany
|
| |
|
|
|
|
|
